Correction
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Paper Information
Record ID:
8943
Author(s):
Flavia Pichiorri
Dario Palmieri
Luciana De Luca
Jessica Consiglio
Jia You
Alberto Rocci
Tiffany Talabere
Claudia Piovan
Alessandro Lagana
Luciano Cascione
Jingwen Guan
Pierluigi Gasparini
Veronica Balatti
Gerard J Nuovo
Vincenzo Coppola
Craig C Hofmeister
Guido Marcucci
John C Byrd
Stefano Volinia
Charles L Shapiro
Michael A Freitas
Carlo M Croce
Dario Palmieri
Luciana De Luca
Jessica Consiglio
Jia You
Alberto Rocci
Tiffany Talabere
Claudia Piovan
Alessandro Lagana
Luciano Cascione
Jingwen Guan
Pierluigi Gasparini
Veronica Balatti
Gerard J Nuovo
Vincenzo Coppola
Craig C Hofmeister
Guido Marcucci
John C Byrd
Stefano Volinia
Charles L Shapiro
Michael A Freitas
Carlo M Croce
Publication Date:
April 22, 2013
Retraction Date:
January 19, 2017
(8.8 years years ago)
Subjects:
Institutions:
- Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH 43210
- Division of Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210
- Department of Molecular Virology, Immunology, and Medical Genetics
- College of Medicine, The Ohio State University, Columbus, OH 43210
- Comprehensive Cancer Center
- The Ohio State University, Columbus, OH 43210
- Laboratorio di ricerca pre-clinica/traslazionale, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata, 85028 Rionero in Vulture (PZ), Italy
- Divisione di Ematologia, Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista, 10149 Turin, Italy
- Start-Up Unit, Department of Experimental Oncology, Tumor National Institute, 20133 Milan, Italy
- Department of Clinical and Molecular Biomedicine, University of Catania, 95122 Catania, Italy
- Phylogeny Inc., Powell, OH 43065
- Data Mining for Analysis of Microarrays, Department of Morphology and Embryology, University of Ferrara, 44100 Ferrara, Italy
Countries:
Article Type:
Publisher:
Rockefeller University Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Correction Details
Retraction Reason:
Nature of Retraction:
Correction
Retraction Notice:
10.1084/jem.2012095001172017cCitations (69)
69
Total Citations56
Post-Retraction(81.2%)
13
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
46
After 2+ years
2966
Days since retraction (latest)
Deciphering ovarian cancer heterogeneity through spatial transcriptomics, single-cell profiling, and copy number variations
Songyun Li, Zhuo Wang, Hsien-Da Huang
PLoS ONE
Open Access
Published: Mar 2025
1 citation
1 citation
2966 days after retraction
The functions and modifications of tRNA-derived small RNAs in cancer biology
Aly M A Saad, Kun Zhang, Qianqian Deng et al. (6 authors)
Cancer and Metastasis Reviews
Published: Mar 2025
1 citation
1 citation
2963 days after retraction
Novel Strategy of Antibody Affinity Maturation and Enhancement of Nucleolin‐Mediated Antibody‐Dependent Cellular Cytotoxicity Against Triple‐Negative Breast Cancer
Rita Ribeiro, Jorge M. B. Vítor, Anastasiya Voronovska et al. (5 authors)
Biotechnology Journal
Published: Jan 2025
2904 days after retraction
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang et al. (4 authors)
ACS Nano
Published: Oct 2024
3 citations
3 citations
2819 days after retraction
Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells
Suyanee Thongchot, Krittaya Aksonnam, Jaturawitt Prasopsiri et al. (9 authors)
BMC Medicine
Open Access
Published: Sep 2024
3 citations
3 citations
2799 days after retraction
Role of Extracellular vesicle microRNAs and RNA binding proteins on glioblastoma dynamics and therapeutics development
Shilpi Singh, Clark C. Chen, Stefan Kim et al. (5 authors)
Extracellular Vesicle
Open Access
Published: Sep 2024
6 citations
6 citations
2791 days after retraction
Beyond biomarkers: Exploring the diverse potential of a novel phosphoprotein in lung cancer management
Amirabbas Rostami, Ehsan Ranjbar, Somayeh Amiri et al. (4 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Sep 2024
2782 days after retraction
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release
Yuan Ma, Duoli Xie, Zefeng Chen et al. (11 authors)
Journal of Translational Medicine
Open Access
Published: Jul 2024
7 citations
7 citations
2720 days after retraction
Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma
Xiujuan Yin, Jing Rong, Min Shao et al. (7 authors)
Journal of Nanobiotechnology
Open Access
Published: May 2024
5 citations
5 citations
2670 days after retraction
LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-Myc protein translation and an energy metabolism positive feedback loop
Zhenhua Wu, Yixuan Wang, Jun-Jiao Song et al. (7 authors)
Cell Death and Disease
Open Access
Published: Mar 2024
9 citations
9 citations
2626 days after retraction
Advancing Targeted Combination Chemotherapy in Triple Negative Breast Cancer: Nucleolin Aptamer-Mediated Controlled Drug Release
Yuan MA, Duoli Xie, Xinyang Shen et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Mar 2024
2624 days after retraction
Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
Suyanee Thongchot, Krittaya Aksonnam, Peti Thuwajit et al. (5 authors)
International Journal of Molecular Medicine
Open Access
Published: Jul 2023
23 citations
23 citations
2374 days after retraction
Emerging roles of tRNA-derived small RNAs in cancer biology
Saebyeol Lee, Jungeun Kim, Paul N. Valdmanis et al. (4 authors)
Experimental & Molecular Medicine
Open Access
Published: Jul 2023
32 citations
32 citations
2363 days after retraction
An insight into fluorescence and magnetic resonance bioimaging using a multifunctional polyethyleneimine-passivated gadocarbon dots nanoconstruct assembled with AS1411
Zohreh Farahbakhsh, Mohammad Reza Zamani, Vahid Nasirian et al. (7 authors)
Microchimica Acta
Published: Jun 2023
3 citations
3 citations
2349 days after retraction
An ERK1/2‐driven RNA‐binding switch in nucleolin drives ribosome biogenesis and pancreatic tumorigenesis downstream of RAS oncogene
Muhammad S. Azman, Emilie Louise Alard, Martin Dodel et al. (10 authors)
The EMBO Journal
Open Access
Published: Apr 2023
24 citations
24 citations
2273 days after retraction
CAMSAP3 negatively regulates lung cancer cell invasion and angiogenesis through nucleolin/HIF-1α mRNA complex stabilization
Suthasinee Seephan, Soichiro Sasaki, Onsurang Wattanathamsan et al. (12 authors)
Life Sciences
Published: Apr 2023
9 citations
9 citations
2265 days after retraction
Nucleolin Regulates Pulmonary Artery Smooth Muscle Cell Proliferation under Hypoxia by Modulating miRNA Expression
Jihui Lee, Hara Kang
Cells
Open Access
Published: Mar 2023
4 citations
4 citations
2237 days after retraction
Deregulation of miR-375 Inhibits HOXA5 and Promotes Migration, Invasion, and Cell Proliferation in Breast Cancer
Rajesh Kannan Moorthy, Chandhru Srinivasan, Maheshkumar Kannan et al. (4 authors)
Applied Biochemistry and Biotechnology
Published: Jan 2023
6 citations
6 citations
2198 days after retraction
Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
Miao Chen, Ping Zhou, Yun Kong et al. (10 authors)
Journal of Medicinal Chemistry
Published: Jan 2023
44 citations
44 citations
2178 days after retraction
DriverMP enables improved identification of cancer driver genes
Yangyang Liu, Jiyun Han, Tongxin Kong et al. (6 authors)
GigaScience
Open Access
Published: Dec 2022
1 citation
1 citation
2169 days after retraction
Predicting drug-resistant miRNAs in cancer
Amrita Kundu, Joginder Singh, Jayanta Kumar Pal et al. (4 authors)
Network Modeling Analysis in Health Informatics and Bioinformatics
Published: Dec 2022
1 citation
1 citation
2156 days after retraction
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells
Valeria Unida, Giulia Vindigni, Sofia Raniolo et al. (6 authors)
Pharmaceutics
Open Access
Published: Nov 2022
4 citations
4 citations
2137 days after retraction
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
Lin Zhang, Ling Li, Xia Wang et al. (15 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Sep 2022
73 citations
73 citations
2069 days after retraction
Cancer therapeutics strategy using nano-carrier mediated natural drugs
Siuli Shaw, Pushpendra Singh, Raghvendra Kumar Mishra et al. (6 authors)
Journal of Achievements of Materials and Manufacturing Engineering
Published: Sep 2022
2 citations
2 citations
2051 days after retraction
A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs
Xuhang Liu, Wenbin Mei, Veena Padmanaban et al. (8 authors)
Molecular Cell
Open Access
Published: Jun 2022
57 citations
57 citations
1959 days after retraction
In silico study predicts a key role of <scp>RNA</scp>‐binding domains 3 and 4 in <scp>nucleolin–miRNA</scp> interactions
Avdar San, Dario Palmieri, Anjana Saxena et al. (4 authors)
Proteins Structure Function and Bioinformatics
Open Access
Published: May 2022
3 citations
3 citations
1933 days after retraction
Overexpression of Nucleolin and Associated Genes in Prostate Cancer
Virginie Firlej, Pascale Soyeux, Maya Nourieh et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2022
11 citations
11 citations
1916 days after retraction
Inhibitory effect of aptamer-carbon dot nanomaterial-siRNA complex on the metastasis of hepatocellular carcinoma cells by interfering with FMRP
Xiaoliang Zhao, Jie Yang, Jing Zhang et al. (7 authors)
European Journal of Pharmaceutics and Biopharmaceutics
Published: Mar 2022
20 citations
20 citations
1896 days after retraction
Detoxification strategies of triptolide based on drug combinations and targeted delivery methods
Zhiwen Cao, Bin Liu, Li Li et al. (6 authors)
Toxicology
Published: Feb 2022
11 citations
11 citations
1860 days after retraction
PIWI-interacting RNA-23210 protects against acetaminophen-induced liver injury by targeting HNF1A and HNF4A
Lin Xu, Wendi Chen, Jing Chen et al. (12 authors)
Biochemical Pharmacology
Published: Dec 2021
14 citations
14 citations
1804 days after retraction
An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
Muhammad S. Azman, Martin Dodel, Federica Capraro et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2021
1792 days after retraction
Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
Yi‐An Chen, Cheau-Ling Ho, Min-Tzu Ku et al. (8 authors)
Scientific Reports
Open Access
Published: Nov 2021
8 citations
8 citations
1763 days after retraction
Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling
Seong-Jae Lee, Kyoung‐Min Choi, Geul Bang et al. (11 authors)
Cancers
Open Access
Published: Jun 2021
12 citations
12 citations
1600 days after retraction
Ultrasensitive plasmon enhanced Raman scattering detection of nucleolin using nanochannels of 3D hybrid plasmonic metamaterial
Cai-Feng Shi, Zhong‐Qiu Li, Chen Wang et al. (5 authors)
Biosensors and Bioelectronics
Published: Jan 2021
17 citations
17 citations
1469 days after retraction
Mechanisms underlying reproductive toxicity induced by nickel nanoparticles identified by comprehensive gene expression analysis in GC-1 spg cells
Lu Kong, Yongya Wu, Wangcheng Hu et al. (6 authors)
Environmental Pollution
Published: Jan 2021
12 citations
12 citations
1468 days after retraction
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
Laura Sofia Soares Carvalho, Nélio Gonçalves, Nuno A. Fonseca et al. (4 authors)
Pharmaceuticals
Open Access
Published: Jan 2021
44 citations
44 citations
1455 days after retraction
RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabrizio Fabbiano, Jessica Corsi, Elena Gurrieri et al. (6 authors)
Journal of Extracellular Vesicles
Open Access
Published: Dec 2020
216 citations
216 citations
1412 days after retraction
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs
Tyler Sheetz, Joseph Mills, Anna Tessari et al. (14 authors)
Cancers
Open Access
Published: Jul 2020
10 citations
10 citations
1268 days after retraction
Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin
Shimaa Soliman, Aaron E. Stark, Miranda L. Gardner et al. (15 authors)
Scientific Reports
Open Access
Published: Apr 2020
9 citations
9 citations
1195 days after retraction
Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer
Jiaxuan He, Tianhuan Peng, Yongbo Peng et al. (7 authors)
Journal of the American Chemical Society
Published: Jan 2020
132 citations
132 citations
1083 days after retraction
From single cells to complex tissues in applications of surface-enhanced Raman scattering
Gregory Q. Wallace, Jean‐François Masson
The Analyst
Published: Jan 2020
33 citations
33 citations
1077 days after retraction
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
Lei Ding, Huan Gu, Xianhui Xiong et al. (9 authors)
Cells
Open Access
Published: Nov 2019
135 citations
135 citations
1037 days after retraction
Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis
Rama Jayaraj, Madhav Madurantakam Royam, Sankaranarayanan Gomathinayagam et al. (16 authors)
Cells
Open Access
Published: Oct 2019
48 citations
48 citations
998 days after retraction
A novel 3'‐tRNA<sup>Glu</sup>‐derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin
Maurizio Falconi, Mara Giangrossi, María Zabaleta et al. (13 authors)
The FASEB Journal
Open Access
Published: Sep 2019
77 citations
77 citations
981 days after retraction
“In vitro” behaviour of aptamer-functionalized polymeric nanocapsules loaded with 5-fluorouracil for targeted therapy
Delia Mihaela Raţă, Anca Niculina Cadinoiu, Leonard Ionuţ Atanase et al. (8 authors)
Materials Science and Engineering C
Published: May 2019
88 citations
88 citations
861 days after retraction
Effect of nucleolin on adriamycin resistance via the regulation of B‐cell lymphoma 2 expression in Burkitt's lymphoma cells
Xuqiao Mei, Yanxin Chen, Donghui Gan et al. (12 authors)
Journal of Cellular Physiology
Open Access
Published: May 2019
4 citations
4 citations
855 days after retraction
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
Simona Camorani, Monica Fedele, Antonella Zannetti et al. (4 authors)
Pharmaceuticals
Open Access
Published: Nov 2018
47 citations
47 citations
663 days after retraction
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
Flora Nguyen Van Long, Audrey Lardy-Cléaud, Susan E. Bray et al. (13 authors)
Cancers
Open Access
Published: Oct 2018
17 citations
17 citations
641 days after retraction
Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway
Seung-Hyun Shin, Ga Young Lee, Mingyu Lee et al. (7 authors)
Nature Communications
Open Access
Published: Oct 2018
71 citations
71 citations
620 days after retraction
Phosphorylation of nucleolin is indispensable to upregulate miR‐21 and inhibit apoptosis in cardiomyocytes
Zhongyi Tong, Yuting Tang, Bimei Jiang et al. (7 authors)
Journal of Cellular Physiology
Published: Sep 2018
15 citations
15 citations
596 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #39505
Oct 03, 2022Quick Stats
Total Citations:
69
Years Since Retraction:
8.8 years
Open Access:
Yes
Last Checked:
Never